Evidence map›Paper›PMID 35937011›Full record

ArticleClinical case reports2022

Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin.

Kaori Nakatani, Kenji Momo, Takashi Mimura, Eri Yoshiizumi, Tadanori Sasaki

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kaori NakataniDepartment of Hospital Pharmaceutics, School of Pharmacy Showa University Shinagawa-ku Japan.ORCID https://orcid.org/0000-0002-9973-229X
Kenji MomoDepartment of Hospital Pharmaceutics, School of Pharmacy Showa University Shinagawa-ku Japan.ORCID https://orcid.org/0000-0001-9856-0097
Takashi MimuraDepartment of Obstetrics and Gynecology, School of Medicine Showa University Shinagawa-ku Japan.
Eri YoshiizumiDepartment of Obstetrics and Gynecology, School of Medicine Showa University Shinagawa-ku Japan.
Tadanori SasakiDepartment of Pharmacy Showa University Hospital Shinagawa-ku Japan.
Showa University Hospital · JPShowa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this report, we present a 37-year-old woman with villous cancer who developed AKI after co-administration of VCM and TAZ/PIPC. Trough concentration of VCM reach a toxic level. Finally, she recovered on day 17.

Indexed as

acute kidney injurydrug–drug interactiontazobactam/piperacillinvancomycin

Identifiers

PMID35937011
PMCPMC9347319
OpenAlexW4289597617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.